Shoshanna Fischhoff

We look back at an incredible year by numbers and a timeline of key moments.

Lifestyle Intervention Research Covered by The Michigan Daily: "High-intensity exercise, calorie restriction reduces nerve damage in prediabetic mice, UMich study finds."

The research compared the effects of high-intensity interval training, caloric restriction, or their combination on improving metabolically acquired peripheral neuropathy (PN).

Researchers looked at medication cost trends for the five most common neurologic conditions.

Researchers compared two diagnostic tools used in neuropathy, one much less invasive, to understand which was more effective.

Researchers found that participants with ALS who had an older biological age compared to their chronological age had shorter survival; the findings were most pronounced in males and those in high-risk occupations.

The NeuroNetwork for Emerging Therapies welcomes a new postdoctoral fellow specializing in biostatistics.

The Osher Lifelong Learning Institute chose Eva L. Feldman, M.D., Ph.D., to be part of its Alfred Gourdji Distinguished Lectures Series.

NeuroNetwork faculty member earns the Early Distinguished Career Award for his exemplary leadership in research, education and clinical care.

The Department of Neurosurgery announced that Eva Feldman, M.D., Ph.D., would receive a joint appointment as a Professor of Neurosurgery.

A knowledge exchange from across the pond has brought two visiting scholars from Europe to the NeuroNetwork for Emerging Therapies lab.

His research will investigate neuron dysregulation in Alzheimer’s disease and other disorders with the goal of developing new therapeutic approaches.

Mohamed Noureldein, Ph.D., and Samuel Teener were awarded the Simona Frontini Young Investigators Award for Most Innovative Research Presentation.

A 27-year-old University of Michigan alumna turned an ALS diagnosis into an opportunity to create a community of support for those like her—young women faced with the deadly disease.

Dr. Kevin Chen led a team that reviewed “Stem cell therapeutics and gene therapy for neurologic disorders.”